Below are the best articles we could find on Psychedelic Research and depression.
CLEAR ALL
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.
The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).
1
The new research looked at cancer patients who took part in a study nearly five years ago.
A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.
3
Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.
The party line of the microdosing community is that it helps with feelings of depression and anxiety (depending on the drug and the severity of the illness), and can make general improvements to your day-to-day life — from focus and productivity (it’s a Silicon Valley hack) to sleep and sex drive.
2
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.
